Filing Details

Accession Number:
0001291656-15-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-16 11:26:15
Reporting Period:
2015-03-12
Filing Date:
2015-03-16
Accepted Time:
2015-03-16 11:26:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
880771 Sciclone Pharmaceuticals Inc SCLN Pharmaceutical Preparations (2834) 943116852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1291656 Wai-Shun Wilson Cheung 950 Tower Lane, Suite 900
Foster City CA 94404
Cfo & Senior Vp, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-03-12 7,803 $9.07 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2014.